Sphingolipid metabolites in inflammatory disease

Nature

Volumn 510, Issue 7503, 2014, Pages 58-67

  MacEyka, Michael ^a   Spiegel, Sarah ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CERAMIDE; CYTOSOLIC PHOSPHOLIPASE A2; DIPEPTIDYL CARBOXYPEPTIDASE; FINGOLIMOD; G PROTEIN COUPLED RECEPTOR; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOETHANOLAMINE; SERINE PALMITOYLTRANSFERASE; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOSINE 1 PHOSPHATE; VERY LOW DENSITY LIPOPROTEIN;

DISEASE CONTROL; DISEASE INCIDENCE; LIPID; METABOLISM; METABOLITE; MOLECULAR ANALYSIS; SIGNALING;

APOPTOSIS; ASTHMA; AUTONOMIC NEUROPATHY; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL MIGRATION; CELL SURVIVAL; CHRONIC INFLAMMATION; DENDRITIC CELL; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY DISEASE; LIPID METABOLISM; MACROPHAGE; MAST CELL; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ADIPOKINES; ANIMALS; AUTOIMMUNE DISEASES; CERAMIDES; ENDOTHELIUM; HUMANS; INFLAMMATION; LYMPHOCYTES; LYSOPHOSPHOLIPIDS; SIGNAL TRANSDUCTION; SPHINGOLIPIDS; SPHINGOSINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84901936622     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature13475     Document Type: Review

References (123)

1. Thudichum, J. L. W. A Treatise on the Chemical Constitution of Brain (Bailliere and Cox, 1884).
2. Hannun, Y. A. & Obeid, L. M. Principles of bioactive lipid signalling: lessons from sphingolipids. Nature Rev. Mol. Cell Biol. 9, 139-150 (2008).
3. Spiegel, S. & Milstien, S. The outs and the ins of sphingosine-1-phosphate in immunity. Nature Rev. Immunol. 11, 403-415 (2011).
4. Brinkmann, V. et al. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nature Rev. Drug Discov. 9, 883-897 (2010).
5. Garofalo, K. et al. Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1. J. Clin. Invest. 121, 4735-4745 (2011).
6. Breslow, D. K. et al. Orm family proteins mediate sphingolipid homeostasis. Nature 463, 1048-1053 (2010).
7. Moffatt, M. F. et al. A large-scale, consortium-based genome wide association study of asthma. N. Engl. J. Med. 363, 1211-1221 (2010).
8. Hanada, K. Co-evolution of sphingomyelin and the ceramide transport protein CERT. Biochim. Biophys. Acta 1841, 704-719 (2014).
9. D'Angelo, G., Rega, L. R. & De Matteis, M. A. Connecting vesicular transport with lipid synthesis: FAPP2. Biochim. Biophys. Acta 1821, 1089-1095 (2012).
10. Dobrosotskaya, I. Y., Seegmiller, A. C., Brown, M. S., Goldstein, J. L. & Rawson, R. B. Regulation of SREBP processing and membrane lipid production by phospholipids in Drosophila. Science 296, 879-883 (2002).
11. Nakahara, K. et al. The Sjogren-Larsson syndrome gene encodes a hexadecenal dehydrogenase of the sphingosine 1-phosphate degradation pathway. Mol. Cell 46, 461-471 (2012).
12. Kharel, Y. et al. Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate. Biochem. J. 440, 345-353 (2011).
13. Pappu, R. et al. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 316, 295-298 (2007).
14. Venkataraman, K. et al. Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ. Res. 102, 669-676 (2008).
15. Pham, T. H. et al. Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning. J. Exp. Med. 207, 17-27 (2010).
16. Mendoza, A. et al. The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate. Cell Rep. 2, 1104-1110 (2012).
17. Fukuhara, S. et al. The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. J. Clin. Invest. 122, 1416-1426 (2012).
18. Quehenberger, O. et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lipid Res. 51, 3299-3305 (2010).
19. Christoffersen, C. et al. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc. Natl Acad. Sci. USA 108, 9613-9618 (2011).
20. Liu, M. et al. Hepatic ApoM overexpression stimulates formation of larger, ApoM/S1P-enriched plasma HDL. J. Biol. Chem. 289, 2801-2814 (2014).
21. Kurano, M. et al. Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M. Atherosclerosis 229, 102-109 (2013).
22. Suzuki, E., Handa, K., Toledo, M. S. & Hakomori, S. Sphingosine-dependent apoptosis: a unified concept based on multiple mechanisms operating in concert. Proc. Natl Acad. Sci. USA 101, 14788-14793 (2004).
23. Jenkins, R. W. et al. Regulation of CC ligand 5/RANTES by acid sphingomyelinase and acid ceramidase. J. Biol. Chem. 286, 13292-13303 (2011).
24. Xiong, Y. et al. Sphingosine kinases are not required for inflammatory responses in macrophages. J. Biol. Chem. 288, 32563-32573 (2013).
25. Pitson, S. M. et al. Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J. 22, 5491-5500 (2003).
26. Snider, A. J. et al. A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis. FASEB J. 23, 143-152 (2009).
27. Price, M. M. et al. A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell-dependent murine model of allergic asthma. J. Allergy Clin. Immunol. 131, 501-511 (2013).
28. Holland, W. L. et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nature Med. 17, 55-63 (2011).
29. Holland, W. L. et al. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J. Clin. Invest. 121, 1858-1870 (2011).
30. Kitano, M. et al. Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression. Arthritis Rheum. 54, 742-753 (2006); erratum 54, 1704 (2006).
31. Majumdar, I. & Mastrandrea, L. D. Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome. Endocrine 41, 442-449 (2012).
32. Canals, D., Roddy, P. & Hannun, Y. A. Protein phosphatase 1α mediates ceramide-induced ERM protein dephosphorylation: a novel mechanism independent of phosphatidylinositol 4, 5-biphosphate (PIP2) and myosin/ERM phosphatase. J. Biol. Chem. 287, 10145-10155 (2012).
33. Saddoughi, S. A. et al. Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis. EMBO Mol. Med. 5, 105-121 (2013).
34. Fox, T. E. et al. Ceramide recruits and activates protein kinase C ζ (PKC ζ) within structured membrane microdomains. J. Biol. Chem. 282, 12450-12457 (2007).
35. Henry, B., Ziobro, R., Becker, K. A., Kolesnick, R. & Gulbins, E. Acid sphingomyelinase. Handb. Exp. Pharmacol. 215, 77-88 (2013).
36. Pettus, B. J. et al. Ceramide-1-phosphate is a direct activator of cytosolic phospholipase A2. J. Biol. Chem. 279, 11320-11326 (2004).
37. Tauzin, L. et al. Effects of ceramide-1-phosphate on cultured cells: dependence on dodecane in the vehicle. J. Lipid Res. 48, 66-76 (2007).
38. Simanshu, D. K. et al. Non-vesicular trafficking by a ceramide-1-phosphate transfer protein regulates eicosanoids. Nature 500, 463-467 (2013).
39. Lamour, N. F. et al. Ceramide kinase regulates the production of tumor necrosis factor alpha (TNFα) via inhibition of TNFα-converting enzyme. J. Biol. Chem. 286, 42808-42817 (2011).
40. Lee, M. J. et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 279, 1552-1555 (1998).
41. Hla, T. & Dannenberg, A. J. Sphingolipid signaling in metabolic disorders. Cell Metab. 16, 420-434 (2012).
42. Cyster, J. G. & Schwab, S. R. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu. Rev. Immunol. 30, 69-94 (2012).
43. Green, J. A. et al. The sphingosine 1-phosphate receptor S1P2 maintains the homeostasis of germinal center B cells and promotes niche confinement. Nature Immunol. 12, 672-680 (2011).
44. Takabe, K. & Spiegel, S. Export of sphingosine-1-phosphate and cancer progression. J. Lipid Res. http://dx.doi.org/10.1194/jlr.R046656 (2014).
45. Hanson, M. A. et al. Crystal structure of a lipid G protein-coupled receptor. Science 335, 851-855 (2012).
46. Alvarez, S. E. et al. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 465, 1084-1088 (2010).
47. Harikumar, K. B. et al. K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5. Nature Immunol. 15, 231-238 (2014).
48. Hait, N. C. et al. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325, 1254-1257 (2009).
49. Ihlefeld, K., Claas, R. F., Koch, A., Pfeilschifter, J. M. & Meyer Zu Heringdorf, D. Evidence for a link between histone deacetylation and Ca2+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts. Biochem. J. 447, 457-464 (2012).
50. Nguyen-Tran, D. H. et al. Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy. Dis. Model. Mech. 7, 41-54 (2014).
51. Petrache, I., Petrusca, D. N., Bowler, R. P. & Kamocki, K. Involvement of ceramide in cell death responses in the pulmonary circulation. Proc. Am. Thorac. Soc. 8, 492-496 (2011).
52. Lee, M. J. et al. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 99, 301-312 (1999).
53. Garcia, J. G. et al. Sphingosine-1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J. Clin. Invest. 108, 689-701 (2001).
54. Natarajan, V. et al. Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury. Am. J. Respir. Cell Mol. Biol. 49, 6-17 (2013).
55. Zhang, Q. J. et al. Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex. Diabetes 61, 1848-1859 (2012).
56. Predescu, S. et al. Platelet activating factor-induced ceramide micro-domains drive endothelial NOS activation and contribute to barrier dysfunction. PLoS ONE 8, e75846 (2013).
57. Camerer, E. et al. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J. Clin. Invest. 119, 1871-1879 (2009).
58. Herzog, B. H. et al. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature 502, 105-109 (2013).
59. Kumaraswamy, S. B., Linder, A., Akesson, P. & Dahlback, B. Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes. Crit. Care 16, R60 (2012).
60. Cui, H. et al. Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice. J. Allergy Clin. Immunol. 132, 1205-1214 (2013).
61. Zhang, G. et al. Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation. Blood 122, 443-455 (2013).
62. Teijaro, J. R. et al. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 146, 980-991 (2011).
63. Teijaro, J. R., Walsh, K. B., Rice, S., Rosen, H. & Oldstone, M. B. Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection. Proc. Natl Acad. Sci. USA 111, 3799-3804 (2014).
64. Rivera, J., Proia, R. L. & Olivera, A. The alliance of sphingosine-1-phosphate and its receptors in immunity. Nature Rev. Immunol. 8, 753-763 (2008).
65. Chi, H. Sphingosine-1-phosphate and immune regulation: trafficking and beyond. Trends Pharmacol. Sci. 32, 16-24 (2011).
66. Takada, K. et al. Kruppel-like factor 2 is required for trafficking but not quiescence in postactivated T cells. J. Immunol. 186, 775-783 (2011).
67. Faroudi, M. et al. Critical roles for Rac GTPases in T-cell migration to and within lymph nodes. Blood 116, 5536-5547 (2010).
68. Arnon, T. I. et al. GRK2-dependent S1PR1 desensitization is required for lymphocytes to overcome their attraction to blood. Science 333, 1898-1903 (2011).
69. Grigorova, I. L., Panteleev, M. & Cyster, J. G. Lymph node cortical sinus organization and relationship to lymphocyte egress dynamics and antigen exposure. Proc. Natl Acad. Sci. USA 107, 20447-20452 (2010).
70. Skon, C. N. et al. Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells. Nature Immunol. 14, 1285-1293 (2013).
71. Arnon, T. I., Horton, R. M., Grigorova, I. L. & Cyster, J. G. Visualization of splenic marginal zone B-cell shuttling and follicular B-cell egress. Nature 493, 684-688 (2013).
72. Baker, D. A., Barth, J., Chang, R., Obeid, L. M. & Gilkeson, G. S. Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-α-induced arthritis. J. Immunol. 185, 2570-2579 (2010).
73. Michaud, J., Kohno, M., Proia, R. L. & Hla, T. Normal acute and chronic inflammatory responses in sphingosine kinase 1 knockout mice. FEBS Lett. 580, 4607-4612 (2006).
74. Puneet, P. et al. Retraction. Science 341, 342 (2013).
75. Zemann, B. et al. Normal neutrophil functions in sphingosine kinase type 1 and 2 knockout mice. Immunol. Lett. 109, 56-63 (2007).
76. Grin'kina, N. M. et al. Sphingosine kinase 1 deficiency exacerbates LPS-induced neuroinflammation. PLoS ONE 7, e36475 (2012).
77. Di, A. et al. A novel function of sphingosine kinase 1 suppression of JNK activity in preventing inflammation and injury. J. Biol. Chem. 285, 15848-15857 (2010).
78. Liang, J. et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer Cell 23, 107-120 (2013).
79. Clarke, C. J., Truong, T. G. & Hannun, Y. A. Role for neutral sphingomyelinase-2 in tumor necrosis factor alpha-stimulated expression of vascular cell adhesion molecule-1 (VCAM) and intercellular adhesion molecule-1 (ICAM) in lung epithelial cells: p38 MAPK is an upstream regulator of nSMase2. J. Biol. Chem. 282, 1384-1396 (2007).
80. Xia, P. et al. Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-α signaling. J. Biol. Chem. 277, 7996-8003 (2002).
81. Billich, A. et al. Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1β and TNF-α induced production of inflammatory mediators. Cell. Signal. 17, 1203-1217 (2005).
82. Pettus, B. J. et al. The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-α. FASEB J. 17, 1411-1421 (2003).
83. Adada, M. M. et al. Sphingosine kinase 1 regulates tumor necrosis factor-mediated RANTES induction through p38 mitogen-activated protein kinase but independently of nuclear factor B activation. J. Biol. Chem. 288, 27667-27679 (2013).
84. Blackwell, K. et al. Two coordinated mechanisms underlie tumor necrosis factor alpha-induced immediate and delayed IκB kinase activation. Mol. Cell. Biol. 33, 1901-1915 (2013).
85. Dennis, E. A. et al. A mouse macrophage lipidome. J. Biol. Chem. 285, 39976-39985 (2010).
86. Sims, K. et al. Kdo2-lipid A, a TLR4-specific agonist, induces de novo sphingolipid biosynthesis in RAW264.7 macrophages, which is essential for induction of autophagy. J. Biol. Chem. 285, 38568-38579 (2010).
87. Levine, B., Mizushima, N. & Virgin, H. W. Autophagy in immunity and inflammation. Nature 469, 323-335 (2011).
88. Ali, M. et al. Altering the sphingolipid acyl chain composition prevents LPS/GLN-mediated hepatic failure in mice by disrupting TNFR1 internalization. Cell Death Dis. 4, e929 (2013).
89. Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860-867 (2006).
90. Chavez, J. A. & Summers, S. A. A ceramide-centric view of insulin resistance. Cell Metab. 15, 585-594 (2012).
91. Park, J. W. et al. Ablation of very long acyl chain sphingolipids causes hepatic insulin resistance in mice due to altered detergent-resistant membranes. Hepatology 57, 525-532 (2013).
92. Vandanmagsar, B. et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nature Med. 17, 179-188 (2011).
93. Youm, Y. H. et al. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab. 18, 519-532 (2013).
94. Youm, Y. H. et al. The Nlrp3 inflammasome promotes age-related thymic demise and immunosenescence. Cell Rep. 1, 56-68 (2012).
95. Yamauchi, T. et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Med. 8, 1288-1295 (2002).
96. Wang, Y. et al. Adiponectin inhibits tumor necrosis factor-α- induced vascular inflammatory response via caveolin-mediated ceramidase recruitment and activation. Circ. Res. 114, 792-805 (2014).
97. Holland, W. L. et al. An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab. 17, 790-797 (2013).
98. Lin, Z. et al. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. Cell Metab. 17, 779-789 (2013).
99. Mietla, J. A. et al. Characterization of eicosanoid synthesis in a genetic ablation model of ceramide kinase. J. Lipid Res. 54, 1834-1847 (2013).
100. Hankins, J. L., Fox, T. E., Barth, B. M., Unrath, K. A. & Kester, M. Exogenous ceramide-1-phosphate reduces lipopolysaccharide (LPS)-mediated cytokine expression. J. Biol. Chem. 286, 44357-44366 (2011).
101. Granado, M. H. et al. Ceramide 1-phosphate (C1P) promotes cell migration Involvement of a specific C1P receptor. Cell. Signal. 21, 405-412 (2009).
102. Mandala, S. et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296, 346-349 (2002).
103. Choi, J. W. et al. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proc. Natl Acad. Sci. USA 108, 751-756 (2011).
104. Gergely, P. et al. The selective S1P receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate: translation from preclinical to clinical studies. Br. J. Pharmacol. 167, 1035-1047 (2012).
105. Oo, M. L. et al. Engagement of S1P1-degradative mechanisms leads to vascular leak in mice. J. Clin. Invest. 121, 2290-2300 (2011).
106. Tsunemi, S. et al. Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model. Clin. Immunol. 136, 197-204 (2010).
107. Schwab, S. R. et al. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309, 1735-1739 (2005).
108. Bagdanoff, J. T. et al. Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E)-1-(4-((1R,2S,3R)-1,2,3, 4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime (LX2931) and (1R,2S,3R)-1-(2-(Isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932). J. Med. Chem. 53, 8650-8662 (2010).
109. Khor, B., Gardet, A. & Xavier, R. J. Genetics and pathogenesis of inflammatory bowel disease. Nature 474, 307-317 (2011).
110. Daniel, C. et al. FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions. Mol. Immunol. 44, 3305-3316 (2007).
111. Sanada, Y. et al. Therapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitis. PLoS ONE 6, e23933 (2011).
112. Ullman, T. A. & Itzkowitz, S. H. Intestinal inflammation and cancer. Gastroenterology 140, 1807-1816 (2011).
113. Kohno, M. et al. Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation. Mol. Cell. Biol. 26, 7211-7223 (2006).
114. Kawamori, T. et al. Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J. 23, 405-414 (2009).
115. Trifilieff, A. & Fozard, J. R. Sphingosine-1-phosphate-induced airway hyper-reactivity in rodents is mediated by the sphingosine-1-phosphate type 3 receptor. J. Pharmacol. Exp. Ther. 342, 399-406 (2012).
116. Olivera, A. et al. Sphingosine-1-phosphate can promote mast cell hyper-reactivity through regulation of contactin-4 expression. J. Leukoc. Biol. 94, 1013-1024 (2013).
117. Nishiuma, T. et al. Inhalation of sphingosine kinase inhibitor attenuates airway inflammation in asthmatic mouse model. Am. J. Physiol. Lung Cell. Mol. Physiol. 294, L1085-L1093 (2008).
118. Siow, D. L. & Wattenberg, B. W. Mammalian ORMDL proteins mediate the feedback response in ceramide biosynthesis. J. Biol. Chem. 287, 40198-40204 (2012).
119. Çalkan, M. et al. Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. N. Engl. J. Med. 368, 1398-1407 (2013).
120. Miller, M. et al. ORMDL3 is an inducible lung epithelial gene regulating metalloproteases, chemokines, OAS, and ATF6. Proc. Natl Acad. Sci. USA 109, 16648-16653 (2012).
121. Ha, S. G. et al. ORMDL3 promotes eosinophil trafficking and activation via regulation of integrins and CD48. Nature Commun. 4, 2479 (2013).
122. Masini, E. et al. Ceramide: a key signaling molecule in a Guinea pig model of allergic asthmatic response and airway inflammation. J. Pharmacol. Exp. Ther. 324, 548-557 (2008).
123. Worgall, T. S. et al. Impaired sphingolipid synthesis in the respiratory tract induces airway hyperreactivity. Sci. Transl. Med. 5, 186ra67 (2013).